Callan JMB, Inc. engages in a vertically integrated logistics and fulfillment ecosystem that utilizes advanced predictive technology for the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time sensitive industries while ensuring environmental responsibility. The company is headquartered in Spring Branch, Texas and currently employs 18 full-time employees. The company went IPO on 2025-02-05. The firm provides comprehensive alternatives to all logistics solutions and services utilized for frozen shipping in the life sciences industry (personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). Its Ship2Q ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturers specifications equal to new off-the-shelf shipper systems.
CJMB stock price ended at $1.97 on 星期一, after rising 25.48%
On the latest trading day Aug 10, 2026, the stock price of CJMB rose by 25.48%, climbing from $1.59 to $1.97. During the session, the stock saw a volatility of 36.60%, with prices oscillating between a daily low of $1.53 and a high of $2.09. Notably, trading volume dropped by 688.7K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 850.6K shares were traded, equating to a market value of approximately $11.1M.